Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Centre Hospitalier Universitaire De Bordeaux
Sponsor

Centre Hospitalier Universitaire De Bordeaux

France 12 Rue Dubernat, Cs 91286, 33400 Talence, France

About the sponsor

The sponsor is active in gastrointestinal oncology, with studies in rectal cancer, gastric adenocarcinoma, pancreatic cancer, and bile duct cancer. Its oncology portfolio also includes gastroenteropancreatic neuroendocrine tumours, metastatic renal cell carcinoma, refractory solid tumours, and FLT3-mutated acute myeloid leukemia.

  • Rectal cancer and locally recurrent rectal cancer
  • Pancreatic and biliary tract cancers
  • Gastric cancer and neuroendocrine tumours
  • Metastatic renal cell carcinoma and solid tumours
  • Acute myeloid leukemia

Research in this area includes imaging for tumour staging, treatment selection in advanced disease, and strategies for difficult-to-treat malignant conditions.

About Specializations

Centre Hospitalier Universitaire De Bordeaux runs clinical trials in conditions such as Cerebrovascular accident, Urethral valves, Vitiligo, Adenocarcinoma pancreas, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

28 clinical trials

Adenocarcinoma pancreas+1

Recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:(S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
  • Sponsor:Centre Hospitalier Universitaire De Bordeaux

Urethral valves

Recruiting
Registered drug
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Amoxicillin
  • Sponsor:Centre Hospitalier Universitaire De Bordeaux

Medical device site joint infection

Recruiting
Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Gallium Citrate Ga-68
  • Sponsor:Centre Hospitalier Universitaire De Bordeaux

Atrial fibrillation+2

Recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Clopidogrel
  • Sponsor:Centre Hospitalier Universitaire De Bordeaux

Respiratory distress

Recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Rocuronium Bromide
  • Sponsor:Centre Hospitalier Universitaire De Bordeaux

Placenta praevia+1

Recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Tranexamic Acid
  • Sponsor:Centre Hospitalier Universitaire De Bordeaux

Gastroenteropancreatic neuroendocrine tumour disease

Recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Amlodipine Besilate
  • Sponsor:Centre Hospitalier Universitaire De Bordeaux

Cerebrovascular accident+1

Recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Fluorodopa (18F)
  • Sponsor:Centre Hospitalier Universitaire De Bordeaux

Raynaud's phenomenon

Recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Clopidogrel
  • Sponsor:Centre Hospitalier Universitaire De Bordeaux

Rheumatoid arthritis

Recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Adalimumab
  • Sponsor:Centre Hospitalier Universitaire De Bordeaux

Ischaemic stroke

Recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Noradrenaline Tartrate
  • Sponsor:Centre Hospitalier Universitaire De Bordeaux

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

ClinicalTrials.eu

Every clinical trial in Europe, in plain language.

Explore the full ecosystem of clinical research in Europe.

Search trials

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).